Lifecore Biomedical Shareholder Notice: Securities Fraud Class Action Settlement Reached

Grabar Law Office is investigating claims on behalf of Lifecore Biomedical shareholders who held shares before October 7, 2020. A securities class action against the company and certain officers has reached a settlement, alleging false and misleading statements regarding the company's business and financial reporting. Affected shareholders can seek corporate reforms and return of funds at no cost.